{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T17:42:51Z","timestamp":1785692571840,"version":"3.56.0"},"reference-count":126,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0543","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T22:15:09Z","timestamp":1735251309000},"page":"341-353","source":"Crossref","is-referenced-by-count":8,"title":["Ghrelin\u2013LEAP2 interactions along the stomach\u2013liver axis"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1903-406X","authenticated-orcid":false,"given":"Katsuya","family":"Sakai","sequence":"first","affiliation":[{"name":"Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7687-1067","authenticated-orcid":false,"given":"Yuki","family":"Nakazato","sequence":"additional","affiliation":[{"name":"Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9752-7399","authenticated-orcid":false,"given":"Yuki","family":"Shiimura","sequence":"additional","affiliation":[{"name":"Division of Molecular Genetics, Institute of Life Science, Kurume University, Fukuoka 830-0011, Japan"},{"name":"Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3464-6083","authenticated-orcid":false,"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Physiology, Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki 889-2192, Japan"},{"name":"Laboratory of Biomolecular Analysis, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6511-1049","authenticated-orcid":false,"given":"Masamitsu","family":"Nakazato","sequence":"additional","affiliation":[{"name":"Forefront Research Center, Graduate School of Science, Osaka University, Osaka 560-0043, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656\u2013660.","DOI":"10.1038\/45230"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, et al. (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141: 4255\u20134261.","DOI":"10.1210\/en.141.11.4255"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3 Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL (2008) Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132: 387\u2013396.","DOI":"10.1016\/j.cell.2008.01.017"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Nishi Y, Hiejima H, Mifune H, Sato T, Kangawa K, et al. (2005) Developmental changes in the pattern of ghrelin\u2019s acyl modification and the levels of acyl-modified ghrelins in murine stomach. Endocrinology 146: 2709\u20132715.","DOI":"10.1210\/en.2004-0645"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Tsch\u00f6p M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, et al. (2001) Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24: RC19\u2013RC21.","DOI":"10.1007\/BF03351037"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, et al. (2006) Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147: 2306\u20132314.","DOI":"10.1210\/en.2005-1357"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Delhanty PJ, Neggers SJ, van der Lely AJ (2013) Des-acyl ghrelin: a metabolically active peptide. Endocr Dev 25: 112\u2013121.","DOI":"10.1159\/000346059"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Inoue Y, Hayashi Y, Kangawa K, Suzuki Y, Murakami N, et al. (2016) Des-acyl ghrelin prevents heatstroke-like symptoms in rats exposed to high temperature and high humidity. Neurosci Lett 615: 28\u201332.","DOI":"10.1016\/j.neulet.2016.01.003"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9 Shimada T, Furuta H, Doi A, Ariyasu H, Kawashima H, et al. (2014) Des-acyl ghrelin protects microvascular endothelial cells from oxidative stress-induced apoptosis through sirtuin 1 signaling pathway. Metabolism 63: 469\u2013474.","DOI":"10.1016\/j.metabol.2013.12.011"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, et al. (2001) A role for ghrelin in the central regulation of feeding. Nature 409: 194\u2013198.","DOI":"10.1038\/35051587"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yanagi S, Sato T, Kangawa K, Nakazato M (2018) The homeostatic force of ghrelin. Cell Metab 27: 786\u2013804.","DOI":"10.1016\/j.cmet.2018.02.008"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, et al. (2000) Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23: 493\u2013495.","DOI":"10.1007\/BF03343763"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13 Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, et al. (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123: 1120\u20131128.","DOI":"10.1053\/gast.2002.35954"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14 Cowley MA, Smith RG, Diano S, Tsch\u00f6p M, Pronchuk N, et al. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37: 649\u2013661.","DOI":"10.1016\/S0896-6273(03)00063-1"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15 Cowley MA, Smart JL, Rubinstein M, Cerd\u00e1n MG, Diano S, et al. (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480\u2013484.","DOI":"10.1038\/35078085"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Miki K, Maekura R, Nagaya N, Nakazato M, Kimura H, et al. (2012) Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One 7: e35708.","DOI":"10.1371\/journal.pone.0035708"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, et al. (2005) Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 90: 10\u201316.","DOI":"10.1210\/jc.2004-1330"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Isomoto H, Ueno H, Saenko VA, Mondal MS, Nishi Y, et al. (2005) Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol 100: 1711\u20131720.","DOI":"10.1111\/j.1572-0241.2005.41492.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Nabekura H, Islam MN, Sakoda H, Yamaguchi T, Saiki A, et al. (2023) Liver-expressed antimicrobial peptide 2 is a hepatokine that predicts weight loss and complete remission of type 2 diabetes mellitus after vertical sleeve gastrectomy in Japanese individuals. Obes Facts 16: 392\u2013400.","DOI":"10.1159\/000530733"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Gluck EF, Stephens N, Swoap SJ (2006) Peripheral ghrelin deepens torpor bouts in mice through the arcuate nucleus neuropeptide Y signaling pathway. Am J Physiol Regul Integr Comp Physiol 291: R1303\u2013R1309.","DOI":"10.1152\/ajpregu.00232.2006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Szentirmai E, Kap\u00e1s L, Sun Y, Smith RG, Krueger JM (2009) The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice. Proc Natl Acad Sci U S A 106: 14069\u201314074.","DOI":"10.1073\/pnas.0903090106"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Sato T, Oishi K, Koga D, Ida T, Sakai Y, et al. (2021) Thermoregulatory role of ghrelin in the induction of torpor under a restricted feeding condition. Sci Rep 11: 17954.","DOI":"10.1038\/s41598-021-97440-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Islam MN, Mita Y, Maruyama K, Tanida R, Zhang W, et al. (2020) Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents. J Endocrinol 244: 13\u201323.","DOI":"10.1530\/JOE-19-0102"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Inoue Y, Nakahara K, Maruyama K, Suzuki Y, Hayashi Y, et al. (2013) Central and peripheral des-acyl ghrelin regulates body temperature in rats. Biochem Biophys Res Commun 430: 278\u2013283.","DOI":"10.1016\/j.bbrc.2012.10.137"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Schwartz GJ, Moran TH (1994) CCK elicits and modulates vagal afferent activity arising from gastric and duodenal sites. Ann N Y Acad Sci 713: 121\u2013128.","DOI":"10.1111\/j.1749-6632.1994.tb44058.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Krieger JP, Langhans W, Lee SJ (2015) Vagal mediation of GLP-1\u2019s effects on food intake and glycemia. Physiol Behav 152: 372\u2013380.","DOI":"10.1016\/j.physbeh.2015.06.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Krieger JP, Arnold M, Pettersen KG, Lossel P, Langhans W, et al. (2016) Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia. Diabetes 65: 34\u201343.","DOI":"10.2337\/db15-0973"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 de Lartigue G, Ronveaux CC, Raybould HE (2014) Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity. Mol Metab 3: 595\u2013607.","DOI":"10.1016\/j.molmet.2014.06.003"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29 Zhao Q, Yu CD, Wang R, Xu QJ, Dai Pra R, et al. (2022) A multidimensional coding architecture of the vagal interoceptive system. Nature 603: 878\u2013884.","DOI":"10.1038\/s41586-022-04515-5"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30 Williams EK, Chang RB, Strochlic DE, Umans BD, Lowell BB, et al. (2016) Sensory neurons that detect stretch and nutrients in the digestive system. Cell 166: 209\u2013221.","DOI":"10.1016\/j.cell.2016.05.011"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 McDougle M, de Araujo A, Singh A, Yang M, Braga I, et al. (2024) Separate gut-brain circuits for fat and sugar reinforcement combine to promote overeating. Cell Metab 36: 393\u2013407.e7.","DOI":"10.1016\/j.cmet.2023.12.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Powley TL, Phillips RJ (2004) Gastric satiation is volumetric, intestinal satiation is nutritive. Physiol Behav 82: 69\u201374.","DOI":"10.1016\/j.physbeh.2004.04.037"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Berthoud HR, Neuhuber WL (2000) Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 85: 1\u201317.","DOI":"10.1016\/S1566-0702(00)00215-0"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Wang FB, Young YK, Kao CK (2012) Abdominal vagal afferent pathways and their distributions of intraganglionic laminar endings in the rat duodenum. J Comp Neurol 520: 1098\u20131113.","DOI":"10.1002\/cne.22812"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Zhang W, Waise TMZ, Toshinai K, Tsuchimochi W, Naznin F, et al. (2020) Functional interaction between Ghrelin and GLP-1 regulates feeding through the vagal afferent system. Sci Rep 10: 18415.","DOI":"10.1038\/s41598-020-75621-5"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36 Teratani T, Mikami Y, Nakamoto N, Suzuki T, Harada Y, et al. (2020) The liver-brain-gut neural arc maintains the T(reg) cell niche in the gut. Nature 585: 591\u2013596.","DOI":"10.1038\/s41586-020-2425-3"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Kentish S, Li H, Philp LK, O\u2019Donnell TA, Isaacs NJ, et al. (2012) Diet-induced adaptation of vagal afferent function. J Physiol 590: 209\u2013221.","DOI":"10.1113\/jphysiol.2011.222158"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38 Date Y, Toshinai K, Koda S, Miyazato M, Shimbara T, et al. (2005) Peripheral interaction of ghrelin with cholecystokinin on feeding regulation. Endocrinology 146: 3518\u20133525.","DOI":"10.1210\/en.2004-1240"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39 Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, et al. (2010) Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology 138: 1312\u20131320.","DOI":"10.1053\/j.gastro.2009.12.058"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 le Roux CW, Neary NM, Halsey TJ, Small CJ, Martinez-Isla AM, et al. (2005) Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 90: 4521\u20134524.","DOI":"10.1210\/jc.2004-2537"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 de Lartigue G, Barbier de la Serre C, Espero E, Lee J, Raybould HE (2012) Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats. PLoS One 7: e32967.","DOI":"10.1371\/journal.pone.0032967"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Egerod KL, Petersen N, Timshel PN, Rekling JC, Wang Y, et al. (2018) Profiling of G protein-coupled receptors in vagal afferents reveals novel gut-to-brain sensing mechanisms. Mol Metab 12: 62\u201375.","DOI":"10.1016\/j.molmet.2018.03.016"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Davis EA, Wald HS, Suarez AN, Zubcevic J, Liu CM, et al. (2020) Ghrelin signaling affects feeding behavior, metabolism, and memory through the vagus nerve. Curr Biol 30: 4510\u20134518.e6.","DOI":"10.1016\/j.cub.2020.08.069"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Okada T, Waise TMZ, Toshinai K, Mita Y, Sakoda H, et al. (2018) Analysis of peripheral ghrelin signaling <i>via<\/i> the vagus nerve in ghrelin receptor-restored GHSR-null mice. Neurosci Lett 681: 50\u201355.","DOI":"10.1016\/j.neulet.2018.05.035"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Naznin F, Toshinai K, Waise TM, NamKoong C, Md Moin AS, et al. (2015) Diet-induced obesity causes peripheral and central ghrelin resistance by promoting inflammation. J Endocrinol 226: 81\u201392.","DOI":"10.1530\/JOE-15-0139"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Mousseaux D, Le Gallic L, Ryan J, Oiry C, Gagne D, et al. (2006) Regulation of ERK1\/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC\/PKCvarepsilon pathway. Br J Pharmacol 148: 350\u2013365.","DOI":"10.1038\/sj.bjp.0706727"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Shiimura Y, Horita S, Hamamoto A, Asada H, Hirata K, et al. (2020) Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode. Nat Commun 11: 4160.","DOI":"10.1038\/s41467-020-17554-1"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Qin J, Cai Y, Xu Z, Ming Q, Ji SY, et al. (2022) Molecular mechanism of agonism and inverse agonism in ghrelin receptor. Nat Commun 13: 300.","DOI":"10.1038\/s41467-022-27975-9"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Liu H, Sun D, Myasnikov A, Damian M, Baneres JL, et al. (2021) Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren. Nat Commun 12: 6410.","DOI":"10.1038\/s41467-021-26735-5"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Wang Y, Guo S, Zhuang Y, Yun Y, Xu P, et al. (2021) Molecular recognition of an acyl-peptide hormone and activation of ghrelin receptor. Nat Commun 12: 5064.","DOI":"10.1038\/s41467-021-25364-2"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Filipek S (2019) Molecular switches in GPCRs. Curr Opin Struct Biol 55: 114\u2013120.","DOI":"10.1016\/j.sbi.2019.03.017"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW (2003) High constitutive signaling of the ghrelin receptor\u2014identification of a potent inverse agonist. Mol Endocrinol 17: 2201\u20132210.","DOI":"10.1210\/me.2003-0069"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Wang HJ, Geller F, Dempfle A, Sch\u00e4uble N, Friedel S, et al. (2004) Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. J Clin Endocrinol Metab 89: 157\u2013162.","DOI":"10.1210\/jc.2003-031395"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, et al. (2006) Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116: 760\u2013768.","DOI":"10.1172\/JCI25303"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, et al. (2004) Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114: 57\u201366.","DOI":"10.1172\/JCI200421134"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Kodama T, Ashitani J, Matsumoto N, Kangawa K, Nakazato M (2008) Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm Pharmacol Ther 21: 774\u2013779.","DOI":"10.1016\/j.pupt.2008.05.001"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Takata A, Takiguchi S, Miyazaki Y, Miyata H, Takahashi T, et al. (2015) Randomized phase II study of the anti-inflammatory effect of ghrelin during the postoperative period of esophagectomy. Ann Surg 262: 230\u2013236.","DOI":"10.1097\/SLA.0000000000000986"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Zhang M, Wang S, Pan Z, Ou T, Ma J, et al. (2018) AMPK\/NF-\u03baB signaling pathway regulated by ghrelin participates in the regulation of HUVEC and THP1 Inflammation. Mol Cell Biochem 437: 45\u201353.","DOI":"10.1007\/s11010-017-3094-x"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2: 17023.","DOI":"10.1038\/sigtrans.2017.23"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Li W, Wu X, Qu R, Wang W, Chen X, et al. (2017) Ghrelin protects against nucleus pulposus degeneration through inhibition of NF-\u03baB signaling pathway and activation of Akt signaling pathway. Oncotarget 8: 91887\u201391901.","DOI":"10.18632\/oncotarget.19695"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Tanabe S, Fujita Y, Ikuma K, Yamashita T (2018) Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis. Cell Death Dis 9: 1061.","DOI":"10.1038\/s41419-018-1118-4"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Sakoda A, Matsushita T, Nakamura Y, Watanabe M, Shinoda K, et al. (2020) Environmental risk factors for multiple sclerosis in Japanese people. Mult Scler Relat Disord 38: 101872.","DOI":"10.1016\/j.msard.2019.101872"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164: 1079\u20131106.","DOI":"10.1111\/j.1476-5381.2011.01302.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Nakazato Y, Fujita Y, Nakazato M, Yamashita T (2020) Neurons promote encephalitogenic CD4(+) lymphocyte infiltration in experimental autoimmune encephalomyelitis. Sci Rep 10: 7354.","DOI":"10.1038\/s41598-020-64363-z"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Theil MM, Miyake S, Mizuno M, Tomi C, Croxford JL, et al. (2009) Suppression of experimental autoimmune encephalomyelitis by ghrelin. J Immunol 183: 2859\u20132866.","DOI":"10.4049\/jimmunol.0803362"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Souza-Moreira L, Delgado-Maroto V, Morell M, O\u2019Valle F, Del Moral RG, et al. (2013) Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1\/Th17 responses and inducing regulatory T cells. Brain Behav Immun 30: 54\u201360.","DOI":"10.1016\/j.bbi.2013.01.080"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Liu F, Li Z, He X, Yu H, Feng J (2019) Ghrelin attenuates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis involving NLRP3 inflammasome signaling pathway and pyroptosis. Front Pharmacol 10: 1320.","DOI":"10.3389\/fphar.2019.01320"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7: 99\u2013109.","DOI":"10.1038\/nrmicro2070"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Prommer E (2017) Oncology update: anamorelin. Palliat Care 10: 1178224217726336.","DOI":"10.1177\/1178224217726336"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70 Graf SA, Garcia JM (2017) Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy. Drug Des Devel Ther 11: 2325\u20132331.","DOI":"10.2147\/DDDT.S110131"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71 Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH (2018) Cancer-associated cachexia. Nat Rev Dis Primers 4: 17105.","DOI":"10.1038\/nrdp.2017.105"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72 Takayama K, Katakami N, Yokoyama T, Atagi S, Yoshimori K, et al. (2016) Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial. Support Care Cancer 24: 3495\u20133505.","DOI":"10.1007\/s00520-016-3144-z"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73 Krause A, Sillard R, Kleemeier B, Kl\u00fcver E, Maronde E, et al. (2003) Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver. Protein Sci 12: 143\u2013152.","DOI":"10.1110\/ps.0213603"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74 Henriques ST, Tan CC, Craik DJ, Clark RJ (2010) Structural and functional analysis of human liver-expressed antimicrobial peptide 2. Chembiochem 11: 2148\u20132157.","DOI":"10.1002\/cbic.201000400"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75 Wang JH, Li HZ, Shao XX, Nie WH, Liu YL, et al. (2019) Identifying the binding mechanism of LEAP2 to receptor GHSR1a. FEBS J 286: 1332\u20131345.","DOI":"10.1111\/febs.14763"},{"key":"76","doi-asserted-by":"publisher","unstructured":"76 Hocquellet A, Odaert B, Cabanne C, Noubhani A, Dieryck W, et al. (2010) Structure-activity relationship of human liver-expressed antimicrobial peptide 2. Peptides 31: 58\u201366.","DOI":"10.1016\/j.peptides.2009.10.006"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77 Townes CL, Michailidis G, Hall J (2009) The interaction of the antimicrobial peptide cLEAP-2 and the bacterial membrane. Biochem Biophys Res Commun 387: 500\u2013503.","DOI":"10.1016\/j.bbrc.2009.07.046"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78 Ashitani J, Mukae H, Hiratsuka T, Nakazato M, Kumamoto K, et al. (2002) Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest 121: 519\u2013526.","DOI":"10.1378\/chest.121.2.519"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79 Mukae H, Iiboshi H, Nakazato M, Hiratsuka T, Tokojima M, et al. (2002) Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis. Thorax 57: 623\u2013628.","DOI":"10.1136\/thorax.57.7.623"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80 Albillos A, de Gottardi A, Rescigno M (2020) The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol 72: 558\u2013577.","DOI":"10.1016\/j.jhep.2019.10.003"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81 Ishimoto H, Mukae H, Date Y, Shimbara T, Mondal MS, et al. (2006) Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia. Eur Respir J 27: 253\u2013260.","DOI":"10.1183\/09031936.06.00105904"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82 Ashitani J, Mukae H, Hiratsuka T, Nakazato M, Kumamoto K, et al. (2001) Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium avium-intracellulare infection. Chest 119: 1131\u20131137.","DOI":"10.1378\/chest.119.4.1131"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83 Ge X, Yang H, Bednarek MA, Galon-Tilleman H, Chen P, et al. (2018) LEAP2 is an endogenous antagonist of the ghrelin receptor. Cell Metab 27: 461\u2013469.e6.","DOI":"10.1016\/j.cmet.2017.10.016"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84 Krause A, Neitz S, M\u00e4gert HJ, Schulz A, Forssmann WG, et al. (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480: 147\u2013150.","DOI":"10.1016\/S0014-5793(00)01920-7"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85 Howard A, Townes C, Milona P, Nile CJ, Michailidis G, et al. (2010) Expression and functional analyses of liver expressed antimicrobial peptide-2 (LEAP-2) variant forms in human tissues. Cell Immunol 261: 128\u2013133.","DOI":"10.1016\/j.cellimm.2009.11.010"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86 Sakai K, Shiomi K, Mochizuki H, Islam MN, Nabekura H, et al. (2021) Human liver-expressed antimicrobial peptide 2 elevation in the cerebrospinal fluid in bacterial meningitis. Brain Behav 11: e02111.","DOI":"10.1002\/brb3.2111"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87 Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806\u20137810.","DOI":"10.1074\/jbc.M008922200"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88 Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, et al. (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811\u20137819.","DOI":"10.1074\/jbc.M008923200"},{"key":"89","doi-asserted-by":"publisher","unstructured":"89 Billesb\u00f8lle CB, Azumaya CM, Kretsch RC, Powers AS, Gonen S, et al. (2020) Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature 586: 807\u2013811.","DOI":"10.1038\/s41586-020-2668-z"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90 M\u2019Kadmi C, Cabral A, Barrile F, Giribaldi J, Cantel S, et al. (2019) N-terminal liver-expressed antimicrobial peptide 2 (LEAP2) region exhibits inverse agonist activity toward the ghrelin receptor. J Med Chem 62: 965\u2013973.","DOI":"10.1021\/acs.jmedchem.8b01644"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91 Hagemann CA, Zhang C, Hansen HH, Jorsal T, Rigbolt KTG, et al. (2021) Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment. J Clin Endocrinol Metab 106: e966\u2013e981.","DOI":"10.1210\/clinem\/dgaa803"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92 Mani BK, Puzziferri N, He Z, Rodriguez JA, Osborne-Lawrence S, et al. (2019) LEAP2 changes with body mass and food intake in humans and mice. J Clin Invest 129: 3909\u20133923.","DOI":"10.1172\/JCI125332"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93 Islam MN, Nabekura H, Ueno H, Nishida T, Nanashima A, et al. (2024) Liver-expressed antimicrobial peptide 2 is a hepatokine regulated by ghrelin, nutrients, and body weight. Sci Rep 14: 24782.","DOI":"10.1038\/s41598-024-74048-6"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94 Thomas EL, Parkinson JR, Frost GS, Goldstone AP, Dor\u00e9 CJ, et al. (2012) The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 20: 76\u201387.","DOI":"10.1038\/oby.2011.142"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95 Shankar K, Metzger NP, Singh O, Mani BK, Osborne-Lawrence S, et al. (2021) LEAP2 deletion in mice enhances ghrelin\u2019s actions as an orexigen and growth hormone secretagogue. Mol Metab 53: 101327.","DOI":"10.1016\/j.molmet.2021.101327"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96 Newman JC, Verdin E (2017) \u03b2-hydroxybutyrate: a signaling metabolite. Annu Rev Nutr 37: 51\u201376.","DOI":"10.1146\/annurev-nutr-071816-064916"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97 Holm S, Husted AS, Skov LJ, Morville TH, Hagemann CA, et al. (2022) Beta-hydroxybutyrate suppresses hepatic production of the ghrelin receptor antagonist LEAP2. Endocrinology 163: bqac038.","DOI":"10.1210\/endocr\/bqac038"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98 Kulkarni SS, Singh O, Zigman JM (2024) The intersection between ghrelin, metabolism and circadian rhythms. Nat Rev Endocrinol 20: 228\u2013238.","DOI":"10.1038\/s41574-023-00927-z"},{"key":"99","doi-asserted-by":"publisher","unstructured":"99 Coomans CP, van den Berg SA, Lucassen EA, Houben T, Pronk AC, et al. (2013) The suprachiasmatic nucleus controls circadian energy metabolism and hepatic insulin sensitivity. Diabetes 62: 1102\u20131108.","DOI":"10.2337\/db12-0507"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100 Hagemann CA, Jensen MS, Holm S, Gasbjerg LS, Byberg S, et al. (2022) LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men. Cell Rep Med 3: 100582.","DOI":"10.1016\/j.xcrm.2022.100582"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101 Ezquerro S, M\u00e9ndez-Gim\u00e9nez L, Becerril S, Moncada R, Valent\u00ed V, et al. (2016) Acylated and desacyl ghrelin are associated with hepatic lipogenesis, \u03b2-oxidation and autophagy: role in NAFLD amelioration after sleeve gastrectomy in obese rats. Sci Rep 6: 39942.","DOI":"10.1038\/srep39942"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102 Smith BK, Marcinko K, Desjardins EM, Lally JS, Ford RJ, et al. (2016) Treatment of nonalcoholic fatty liver disease: role of AMPK. Am J Physiol Endocrinol Metab 311: E730\u2013E740.","DOI":"10.1152\/ajpendo.00225.2016"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103 Moreno M, Chaves JF, Sancho-Bru P, Ramalho F, Ramalho LN, et al. (2010) Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology 51: 974\u2013985.","DOI":"10.1002\/hep.23421"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104 Mao Y, Zhang S, Yu F, Li H, Guo C, et al. (2015) Ghrelin attenuates liver fibrosis through regulation of TGF-\u03b21 expression and autophagy. Int J Mol Sci 16: 21911\u201321930.","DOI":"10.3390\/ijms160921911"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105 Ma X, Xue X, Zhang J, Liang S, Xu C, et al. (2021) Liver expressed antimicrobial peptide 2 is associated with steatosis in mice and humans. Exp Clin Endocrinol Diabetes 129: 601\u2013610.","DOI":"10.1055\/a-1210-2357"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106 Ezquerro S, Tuero C, Becerril S, Valent\u00ed V, Moncada R, et al. (2023) Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease. Eur J Endocrinol 188: 564\u2013577.","DOI":"10.1093\/ejendo\/lvad071"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107 Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, et al. (2022) Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci 23: 583.","DOI":"10.3390\/ijms23020583"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108 Aslanipour B, Alan M, Demir I (2020) Decreased levels of liver-expressed antimicrobial peptide-2 and ghrelin are related to insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 36: 222\u2013225.","DOI":"10.1080\/09513590.2019.1665646"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109 Yada T, Damdindorj B, Rita RS, Kurashina T, Ando A, et al. (2014) Ghrelin signalling in \u03b2-cells regulates insulin secretion and blood glucose. Diabetes Obes Metab 16 Suppl 1: 111\u2013117.","DOI":"10.1111\/dom.12344"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110 Ohta H, Konishi M, Kobayashi Y, Kashio A, Mochiyama T, et al. (2015) Deletion of the neurotrophic factor neudesin prevents diet-induced obesity by increased sympathetic activity. Sci Rep 5: 10049.","DOI":"10.1038\/srep10049"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111 Vergani E, Bruno C, Gavotti C, Oliva A, Curr\u00f2 D, et al. (2023) Increased levels of plasma neudesin in adult growth hormone deficiency and their relationship with plasma liver-expressed antimicrobial peptide-2 levels: a cross-sectional study. J Endocrinol Invest 46: 1187\u20131195.","DOI":"10.1007\/s40618-022-01974-5"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112 Chen SR, Chen H, Zhou JJ, Pradhan G, Sun Y, et al. (2017) Ghrelin receptors mediate ghrelin-induced excitation of agouti-related protein\/neuropeptide Y but not pro-opiomelanocortin neurons. J Neurochem 142: 512\u2013520.","DOI":"10.1111\/jnc.14080"},{"key":"113","doi-asserted-by":"publisher","unstructured":"113 Dezaki K, Kakei M, Yada T (2007) Ghrelin uses Galphai2 and activates voltage-dependent K<sup>+<\/sup> channels to attenuate glucose-induced Ca2<sup>+<\/sup> signaling and insulin release in islet beta-cells: novel signal transduction of ghrelin. Diabetes 56: 2319\u20132327.","DOI":"10.2337\/db07-0345"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114 Dezaki K, Damdindorj B, Sone H, Dyachok O, Tengholm A, et al. (2011) Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet \u03b2-cells. Diabetes 60: 2315\u20132324.","DOI":"10.2337\/db11-0368"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115 Adriaenssens AE, Svendsen B, Lam BY, Yeo GS, Holst JJ, et al. (2016) Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets. Diabetologia 59: 2156\u20132165.","DOI":"10.1007\/s00125-016-4033-1"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116 Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J (2002) Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 146: 241\u2013244.","DOI":"10.1530\/eje.0.1460241"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117 Kurashina T, Dezaki K, Yoshida M, Sukma Rita R, Ito K, et al. (2015) The \u03b2-cell GHSR and downstream cAMP\/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin. Sci Rep 5: 14041.","DOI":"10.1038\/srep14041"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118 Gupta D, Dowsett GKC, Mani BK, Shankar K, Osborne-Lawrence S, et al. (2021) High coexpression of the ghrelin and LEAP2 receptor GHSR with pancreatic polypeptide in mouse and human islets. Endocrinology 162: bqab148.","DOI":"10.1210\/endocr\/bqab148"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119 Khandekar N, Berning BA, Sainsbury A, Lin S (2015) The role of pancreatic polypeptide in the regulation of energy homeostasis. Mol Cell Endocrinol 418 Pt 1: 33\u201341.","DOI":"10.1016\/j.mce.2015.06.028"},{"key":"120","doi-asserted-by":"crossref","unstructured":"120 Yang CH, Onda DA, Oakhill JS, Scott JW, Galic S, et al. (2021) Regulation of pancreatic \u03b2-cell function by the NPY system. Endocrinology 162: bqab070.","DOI":"10.1210\/endocr\/bqab070"},{"key":"121","doi-asserted-by":"crossref","unstructured":"121 Zhu W, Tanday N, Flatt PR, Irwin N (2023) Pancreatic polypeptide revisited: potential therapeutic effects in obesity-diabetes. Peptides 160: 170923.","DOI":"10.1016\/j.peptides.2022.170923"},{"key":"122","doi-asserted-by":"crossref","unstructured":"122 Kumar R, Salehi A, Rehfeld JF, H\u00f6glund P, Lindstr\u00f6m E, et al. (2010) Proghrelin peptides: desacyl ghrelin is a powerful inhibitor of acylated ghrelin, likely to impair physiological effects of acyl ghrelin but not of obestatin A study of pancreatic polypeptide secretion from mouse islets. Regul Pept 164: 65\u201370.","DOI":"10.1016\/j.regpep.2010.06.005"},{"key":"123","doi-asserted-by":"crossref","unstructured":"123 Qader SS, H\u00e5kanson R, Rehfeld JF, Lundquist I, Salehi A (2008) Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul Pept 146: 230\u2013237.","DOI":"10.1016\/j.regpep.2007.09.017"},{"key":"124","doi-asserted-by":"crossref","unstructured":"124 Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, et al. (2003) Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 88: 3989\u20133992.","DOI":"10.1210\/jc.2003-030630"},{"key":"125","doi-asserted-by":"crossref","unstructured":"125 Yang YJ, Sheu BS, Yang HB, Lu CC, Chuang CC (2012) Eradication of helicobacter pylori increases childhood growth and serum acylated ghrelin levels. World J Gastroenterol 18: 2674\u20132681.","DOI":"10.3748\/wjg.v18.i21.2674"},{"key":"126","doi-asserted-by":"crossref","unstructured":"126 Al-Massadi O, M\u00fcller T, Tsch\u00f6p M, Di\u00e9guez C, Nogueiras R (2018) Ghrelin and LEAP-2: rivals in energy metabolism. Trends Pharmacol Sci 39: 685\u2013694.","DOI":"10.1016\/j.tips.2018.06.004"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/4\/72_EJ24-0543\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:30:20Z","timestamp":1743827420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/4\/72_EJ24-0543\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":126,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0543","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0543"}}